Serum chromogranin-A assay in differential diagnosis of incidentally discovered adrenal masses

Anticancer Research

Volumn 25, Issue 3 A, 2005, Pages 1547-1550

  Giovanella, Luca ^a  

^a ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

Author keywords

Catecholamines; Chromaffin cell; Chromogranin A; Iodine 123 (123I); Metaiodobenzylguanidine (MIBG); Pheochromocytoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; CATECHOLAMINE; CHROMOGRANIN A;

ADRENAL CORTEX ADENOMA; ADRENAL HYPERPLASIA; ADRENAL METASTASIS; ADULT; AGED; ASPIRATION BIOPSY; CATECHOLAMINE RELEASE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SCINTIGRAPHY;

3-IODOBENZYLGUANIDINE; ADRENAL GLAND NEOPLASMS; CHROMOGRANIN A; CHROMOGRANINS; DIAGNOSIS, DIFFERENTIAL; HUMANS; INCIDENTAL FINDINGS; PHEOCHROMOCYTOMA; SENSITIVITY AND SPECIFICITY;

EID: 21244459595     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Kloos RT, Gross MD and Francis IR: Incidentally discovered adrenal masses. Endocrin Rev 16: 460-484, 1995.
2. Plouin PF, Gimenez-Roqueplo AP, La Batide Alanore A, Salenave S and Duclos JM: Recent progress in the diagnosis, prognostic evaluation and treatment of pheochromocytoma. Rev Med Interne 21: 1075-1085, 2000.
3. Rosano TG, Swift TA and Hayes LW: Advances in catecholamine and metabolite measurements for diagnosis of pheochromocytoma. Clin Chem 37: 1854-1867, 1991.
4. Gardet V, Gatta B, Simonnet G, Tabarin A, Chene G, Ducassou D et al: Lessons for an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma. J Hypertens 19: 1029-1035, 2001.
5. Witteles RM, Kaplan EL and Roizen MF: Sensitivity of diagnostic and localization tests for pheochromocytoma in clinical practice. Arch Intern Med 160: 2521-2524, 2000.
6. Takyyuddin MA, Barbosa JA, Hsiao RJ, Parmer RJ and O'Connor DT: Diagnostic value of chromogranin A measured in the circulation. In: Gratzl M and Lanley K (eds): Markers for Neural and Endocrine Cells. VCH, Germany, 1991, pp 191-201.
7. O'Connor DT, Pandian RM, Cervenka JH, Mezger M and Parmer RJ: What is the source and disposition of CgA in normal human plasma? Clin Res 35: 605[abs], 1987.
8. Hsiao RJ, Neumann HPH, Parmer RJ, Barbosa JA and O'Connor DT: Chromogranin A in familial pheochromocytoma: diagnostic screening value, prediction of tumor mass and post-resection kinetics indicating two-compartment distribution. Am J Med 88: 607-613, 1990.
9. Hsiao RJ, Parmer RJ, Takyyuddin MA and O'Connor DT: Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma. Medicine 70: 33-45, 1991.
10. Giovanella L and Ceriani L: Serum chromogranin A immunoradiometric assay in the diagnosis of pheochromocytoma. Int J Biol Markers 17: 130-134, 2002.
11. 123I-MIBG scan in diagnosis of chromaffin-cell derived tumours. Eur J Nucl Med Mol Imaging 30(S2): 161-162, 2003.
12. Degorce F, Goumon Y, Jacquemart L, Vidaud C, Bellanger L, Pons-Anicet D et al: A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245). Br J Cancer 79: 65-71, 1999.
13. Giovanella L, La Rosa S, Ceriani L, Uccella S and Garancini S: Chromogranin A as serum marker of neuroendocrine tumors: comparison with neuron-specific enolase and correlation with immunohistochemical findings. Int J Biol Markers 14: 160-166, 1999.
14. Hernandez FC, Sanchez M, Alvarez A, Diaz J, Pascual R, Perez M et al: A five-year report on experience in the detection of pheochromocytoma. Clin Biochem 33: 649-655, 2000.
15. Graham PE, Smythe GA and Edwards GA: Laboratory diagnosis of pheochromocytoma: which analytes should we measure? Ann Clin Biochem 30: 129-134, 1993.
16. Peaston RT and Lai LC: Biochemical detection of pheochromocytoma: should we still be measuring urinary HMMA? J Clin Pathol 46: 734-737, 1993.
17. Heron HE, Chatellier G, Billaud E, Foos F and Plouin PP: The urinary metanephrine-to-creatinine ratio for the diagnosis of pheochromocytoma. Ann Intern Med 125: 300-303, 1996.
18. Eisenhofer G, Keiser H, Friberg P, Meyez E, Huynh TT, Hiremagalur B et al: Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab 83: 2175-2185, 1998.
19. Bravo EL: Plasma or urinary metanephrines for the diagnosis of pheochromocytoma? That is the question. Ann Intern Med 125: 331-332, 1996.
20. Weissmann C, Jamdar SC and Soo E: Do synthetic adrenergic agents interfere with the measurement of endogenous plasma catecholamine concentration? J Crit Care 10: 72-77, 1995.
21. Aardal S, Aardal NP, Larsen TH, Angeletti RH, Stridsberg M, Taupenot L et al: Human pheochromocytoma: different patterns of catecholamines and chromogranins in the intact tumour, urine and serum in clinically unsuspected cases. Scand J Clin Lab Invest 56: 511-523, 1996.
22. d'Herbomez M, Gouze V, Huglo D, Nocaudie M, Pattou F, Proye C et al: Chromogranin A assay and (13I)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma. J Nucl Med 42: 993-997, 2001.